サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404817

院内感染診断市場規模、シェア、動向分析レポート：検査タイプ別、感染タイプ別、製品タイプ別、地域別、セグメント別予測、2023年～2030年

Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Conventional), By Infection Type (UTI, Pneumonia), By Product (Consumables), By Type, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 70 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
院内感染診断市場規模、シェア、動向分析レポート：検査タイプ別、感染タイプ別、製品タイプ別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年11月29日
発行: Grand View Research
ページ情報: 英文 70 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

院内感染診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の院内感染診断市場は2030年までに71億5,000万米ドルに達する見込みです。

世界の院内感染診断市場は、2023年から2030年にかけて7.2％の健全なCAGRで成長すると予測されています。市場成長の要因としては、MRSAやC. difficileなどの薬剤耐性病原体の増加、老年人口の高齢化、正確で信頼性の高い結果を短納期で提供する技術的に高度な製品の開拓などが挙げられます。

業界成長のもう一つの要因は、中低所得国からのHAI診断薬需要の増加であり、HAI診断薬市場の需要をさらに押し上げています。ヘルスケア従事者の意識の高まりや政府のイニシアティブの提案が、業界の成長をさらに後押ししています。しかし、先進諸国における院内感染の有病率の低下は、業界の成長を妨げる可能性が高いです。

HAI診断市場は、感染タイプおよび検査タイプに基づいて分類されます。感染タイプ別では、尿路感染（UTI）、血流感染（BSI）、手術部位感染（SSI）、肺炎、その他に区分されます。2015年現在、尿路感染症分野が最大のシェアを占めると推定される一方、肺炎HAI診断薬は2015年から2022年までの期間、最も高いCAGRで成長すると予測されています。HAI診断薬産業はさらに、分子検査とその他の体外検査に細分化されます。分子診断セグメントはシェアが低いが、今後数年で有利な成長が見込まれます。

院内感染診断市場レポートハイライト

  • 消耗品セグメントは、2022年の院内感染診断市場において63.5%の最大売上シェアを占め、HAIの発生率の上昇により、予測期間中最も速いCAGR 7.7%で拡大すると予測されます。
  • 血液検査セグメントは、2022年に65.8％の最大の収益シェアを占め、予測期間中に7.08％の最速CAGRで進展すると予測されています。
  • 欧州が市場を独占し、2022年には34.3％の最大収益シェアを占めました。これは、高い疾病負担、インフラの利用可能性、ヘルスケア支出の増加、急速な技術進歩、政府の積極的な取り組み、患者意識の高まり、主要企業の存在によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 院内感染診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 院内感染診断市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 院内感染診断市場：検査タイプの推定・動向分析

  • 院内感染診断市場：主要ポイント
  • 院内感染診断市場：検査タイプの動向と市場シェア分析、2022年および2030年
  • 従来
    • 従来の市場推計・予測、2018年～2030年
  • 分子
    • 分子市場推計・予測、2018年～2030年

第5章 院内感染診断市場：感染タイプの推定・動向分析

  • 院内感染診断市場：主要ポイント
  • 院内感染診断市場：感染タイプの動向と市場シェア分析、2022年および2030年
  • 尿路感染症
    • 尿路感染症市場推計・予測、2018年～2030年
  • 肺炎
    • 肺炎市場推計・予測、2018年～2030年
  • 手術部位感染
    • 手術部位感染市場推計・予測、2018年～2030年
  • 血流感染症
    • 血流感染症市場推計・予測、2018年～2030年
  • その他
    • その他の感染症市場推計・予測、2018年～2030年

第6章 院内感染診断市場：製品推定・動向分析

  • 院内感染診断市場：主要ポイント
  • 院内感染診断市場：製品動向と市場シェア分析、2022年および2030年
  • 消耗品
    • 消耗品市場推計・予測、2018年～2030年
  • 機器
    • 機器市場推計・予測、2018年～2030年

第7章 院内感染診断市場：タイプの推定・動向分析

  • 院内感染診断市場：主要ポイント
  • 院内感染診断市場：タイプの動きと市場シェア分析、2022年と2030年
  • 血液検査
    • 血液検査市場推計・予測、2018年～2030年
  • 尿検査
    • 尿検査市場推計・予測、2018年～2030年

第8章 院内感染診断市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別の院内感染診断市場：主要ポイント
  • 北米
    • 市場推計・予測、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • BIOMERIEUX
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthcare Private Limited
    • BD (Becton, Dickinson and Company)
    • Hologic, Inc.
    • Meridian Bioscience, Inc.
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • Bioscience, Inc.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America hospital acquired infections diagnostics market, by infection Type, 2018 - 2030 (USD Million)
  • Table 4 North America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 6 North America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 8 U.S. hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 9 U.S. hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 12 Canada hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 13 Canada hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 15 Europe hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 16 Europe hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 17 Europe hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 18 Europe hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Europe hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 20 UK hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 21 UK hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 22 UK hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 25 Germany hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 26 Germany hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 28 France hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 29 France hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 30 France hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 31 France hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Italy hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 33 Italy hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 34 Italy hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Italy hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 37 Spain hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 38 Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 39 Spain hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 40 Denmark hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 41 Denmark hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 42 Denmark hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 43 Denmark hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Sweden hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 45 Sweden hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 46 Sweden hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 47 Sweden hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 48 Norway hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 49 Norway hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 50 Norway hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 Norway hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 57 Japan hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 58 Japan hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 59 Japan hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 Japan hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 61 China hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 62 China hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 63 China hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 64 China hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 65 India hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 66 India hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 67 India hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 68 India hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 69 Australia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 70 Australia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 71 Australia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 72 Australia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 73 Thailand hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 74 Thailand hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 75 Thailand hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 76 Thailand hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 77 South Korea hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 78 South Korea hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 79 South Korea hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Korea hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 81 Latin America hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 82 Latin America hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 83 Latin America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 84 Latin America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 85 Latin America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 87 Brazil hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 88 Brazil hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 89 Brazil hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 90 Mexico hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 91 Mexico hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 92 Mexico hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 93 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 94 Argentina hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 95 Argentina hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 96 Argentina hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 97 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 104 South Africa hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 105 South Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 106 South Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 111 UAE hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 112 UAE hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 113 UAE hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 114 UAE hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 118 Kuwait hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Microneedle Instruments systems: market outlook
  • Fig. 8 Hospital Acquired Infections Diagnostics competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Hospital acquired infections diagnostics market driver impact
  • Fig. 13 Hospital acquired infections diagnostics market restraint impact
  • Fig. 14 Hospital acquired infections diagnostics market strategic initiatives analysis
  • Fig. 15 Hospital acquired infections diagnostics market: Test type movement analysis
  • Fig. 16 Hospital acquired infections diagnostics market: Test type outlook and key takeaways
  • Fig. 17 Molecular market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Conventional market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Hospital acquired infections diagnostics market: Infection type movement analysis
  • Fig. 20 Hospital acquired infections diagnostics market: Infection type outlook and key takeaways
  • Fig. 21 UTI market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pneumonia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Surgical site infection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Blood stream infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Hospital acquired infections diagnostics market: Product movement analysis
  • Fig. 27 Hospital acquired infections diagnostics market: Product outlook and key takeaways
  • Fig. 28 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Hospital acquired infections diagnostics market: Type movement analysis
  • Fig. 31 Hospital Acquired Infections Diagnostics market: Type outlook and key takeaways
  • Fig. 32 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Urinalysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Global hospital acquired infections diagnostics market: Regional movement analysis
  • Fig. 35 Global hospital acquired infections diagnostics market: Regional outlook and key takeaways
  • Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-783-4

Hospital Acquired Infections Diagnostics Market Growth & Trends:

The global hospital acquired infections diagnostics market is expected to reach USD 7.15 billion by 2030, according to a new report by Grand View Research, Inc. The global hospital acquired infections diagnostics market is projected to grow at a healthy CAGR of 7.2% during the period of 2023 to 2030. Factors attributing to the growth of the market are increase in the number of drug-resistant pathogens such as MRSA and C. difficile, advancing age of geriatric population, and development of technologically advanced products that offer accurate and reliable results with low turnaround time.

Another factor contributing to industry growth is the increasing demand of HAI diagnostics from middle and low income countries, further driving demand for HAI diagnostic market. Increasing awareness among healthcare workers and proposed government initiatives are further supporting industry growth. However, decline in the prevalence rate of nosocomial infections in the developed countries is likely to hinder industry growth.

The HAI diagnostics market is categorized on the basis of infection type and test type. On the basis of infection type, the market is segmented into Urinary Tract Infection (UTI), Blood Stream Infection (BSI), Surgical Site Infection (SSI), pneumonia, and others. As of 2015, the urinary tract infection segment was estimated to account for the largest share, whereas the pneumonia HAI diagnostics is projected to grow at the highest CAGR during the period of 2015 to 2022.The HAI diagnostics industry is further segmented into molecular tests and other in-vitro tests. Though the molecular diagnostics segment is estimated to constitute a low share, it is anticipated to witness a lucrative growth in the next few years.

Hospital Acquired Infections Diagnostics Market Report Highlights:

  • The consumables segment held the largest revenue share of 63.5% in the hospital acquired infections diagnostics market in 2022 and is expected to expand at the fastest CAGR of 7.7% over the forecast period, owing to the rising incidence of HAIs.
  • The blood tests segment accounted for the largest revenue share of 65.8% in 2022 and is expected to advance at the fastest CAGR of 7.08% during the forecast period.
  • Europe dominated the market and accounted for the largest revenue share of 34.3% in 2022, owing to the high disease burden, the availability of infrastructure, increased healthcare expenditure, rapid technological advancements, proactive government initiatives, rise in patient awareness, and the presence of major players.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Infection Type
    • 1.1.3. Product
    • 1.1.4. Type
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Infection Type outlook
    • 2.2.3. Product outlook
    • 2.2.4. Type outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hospitals Acquired Infections Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Hospitals Acquired Infections Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Hospitals Acquired Infections Diagnostics Market: Test Type Estimates & Trend Analysis

  • 4.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 4.2. Hospital Acquired Infections Diagnostics Market: Test Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Conventional
    • 4.3.1. Conventional market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Molecular
    • 4.4.1. Molecular market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hospital Acquired Infections Diagnostics Market: Infection Type Estimates & Trend Analysis

  • 5.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 5.2. Hospital Acquired Infections Diagnostics Market: Infection Type Movement & Market Share Analysis, 2022 & 2030
  • 5.3. UTI
    • 5.3.1. UTI market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Pneumonia
    • 5.4.1. Pneumonia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Surgical Site Infection
    • 5.5.1. Surgical site infection market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Blood Stream Infections
    • 5.6.1. Blood stream infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others infections market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hospital Acquired Infections Diagnostics Market: Product Estimates & Trend Analysis

  • 6.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 6.2. Hospital Acquired Infections Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Consumables
    • 6.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Instruments
    • 6.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Hospital Acquired Infections Diagnostics Market: Type Estimates & Trend Analysis

  • 7.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 7.2. Hospital Acquired Infections Diagnostics Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Blood Tests
    • 7.3.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Urinalysis
    • 7.4.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Hospital Acquired Infections Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Hospitals Acquired Infections Diagnostics Market by Region: Key Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Denmark
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Norway
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. BIOMERIEUX
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Abbott
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. F. Hoffmann-La Roche Ltd.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Siemens Healthcare Private Limited
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. BD (Becton, Dickinson and Company)
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Hologic, Inc.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Meridian Bioscience, Inc.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. QIAGEN
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Thermo Fisher Scientific Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Bioscience, Inc.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives